{"id":"NCT03733301","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate to Severe Atopic Dermatitis BREEZE-AD7","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-11-16","primaryCompletion":"2019-07-29","completion":"2019-08-22","firstPosted":"2018-11-07","resultsPosted":"2020-08-11","lastUpdate":"2020-08-11"},"enrollment":329,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Atopic Dermatitis"],"interventions":[{"type":"DRUG","name":"Baricitinib","otherNames":["LY3009104"]},{"type":"DRUG","name":"Topical corticosteroid","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"4 Milligram (mg) Baricitinib","type":"EXPERIMENTAL"},{"label":"2 mg Baricitinib","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of baricitinib in combination with topical corticosteroids (TCS) in participants with moderate to severe atopic dermatitis.","primaryOutcome":{"measure":"Percentage of Participants Achieving Investigator's Global Assessment (IGA) of 0 or 1 With a â‰¥ 2 Point Improvement","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo","deltaMin":14.7,"sd":null},{"arm":"2 mg Baricitinib","deltaMin":23.9,"sd":null},{"arm":"4 mg Baricitinib","deltaMin":30.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.082"},{"comp":"OG000 vs OG002","p":"0.004"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":14},"locations":{"siteCount":68,"countries":["Argentina","Australia","Austria","Germany","Italy","Japan","Poland","South Korea","Spain","Taiwan"]},"refs":{"pmids":["36749121","36255569","34275122","33899152","33826132","33001140"],"seeAlso":["https://www.lillytrialguide.com/en-US/studies/atopic-dermatitis/JAIY"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":108},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Folliculitis"]}}